Comera Life Sciences Inc. (CMRAW) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Comera Life Sciences Inc...

    NASDAQ: CMRAW · Real-Time Price · USD
    0.02
    null (null%)
    At close: Sep 17, 2024, 10:00 PM

    Comera Life Sciences Ratios and Metrics

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.71 -36.54
    PEG Ratio
    		 -0.00 -0.24
    PS Ratio
    		 20.31 604.55
    PB Ratio
    		 -2.06 -13.17
    P/FCF Ratio
    		 -1.31 -49.58
    P/OCF Ratio
    		 -1.32 -51.45
    OCF/S Ratio
    		 -15.43 -11.75
    Debt / Equity Ratio
    		 -0.12 -0.02
    Quick Ratio
    		 0.61 6.49
    Current Ratio
    		 0.61 6.49
    Asset Turnover
    		 0.17 0.04
    Interest Coverage
    		 -587.02 n/a
    Return on Equity
    		 2.88 0.36
    Return on Assets
    		 -4.83 -0.71
    Return on Invested Capital
    		 17.69 -0.83
    Dividend Yield
    		 n/a n/a
    Payout Ratio
    		 n/a n/a
    Gross Profit Margin
    		 0.67 0.50
    Net Profit Margin
    		 -28.44 -16.54
    Pretax Profit Margin
    		 -28.44 -17.05
    Operating Profit Margin
    		 -18.91 -17.31
    FCF Margin
    		 n/a n/a
    EBITDA Margin
    		 -28.25 -16.77

    Add to Watchlist